KANE BIOTECH INC. is a biotechnology company engaged in the development of products to prevent and disperse biofilms. Biofilms are a major cause of a number of serious medical problems including chronic infections and medical device related infections. They develop on surfaces such as catheters, prosthetic implants, teeth, lungs and the urogenital tract. Biofilms are pervasive, costly to deal with and approximately 80% of all human bacterial infections involve biofilms. The healing of chronic wounds alone costs the Unites States health care system $20 Billion per year.
Turning novel discoveries into innovative healthcare solutions
Kane Biotech Inc. is a research and discovery based, growing biotechnology company with expertise in creating products that prevent and disperse bacterial biofilms.
Biofilms develop when bacteria and other microorganisms form a protective environment that acts as a shield against attack. When in a biofilm, bacteria become highly resistant to antibiotics, high temperatures and host immune responses. This resiliency contributes to human health problems such as recurrent urinary tract infections, medical device related infections and tooth decay.
News
April 18, 2007
Kane Biotechand Harland Medical Systems Announce Commercial License Agreementl
> Read more
January 23, 2007
Kane Biotech receives United States patent for methods of reducing biofilm formation
> Read more
Novel approaches to controlling bacterial pathogens
With an understanding of the important role that biofilms play in both the survival and the dominance of bacteria, Kane Biotech believes that solutions to the biofilm problem will play an increasing role in combating infectious diseases. The cost and consequence of infectious diseases continues to increase worldwide, and the opportunity for Kane Biotech to develop unique products that have a positive impact on human health is clear. We are strongly committed to advancing our research and the development of our growing pipeline of products for commercialization.
Kane Biotech has one of the leading collections of biofilm related technologies, positioning us at the forefront of this rapidly developing and vastly underserved field. Our products are designed to make significant contributions to human health problems such as hospital-acquired medical device related infections and tooth decay.
